Nuvation Bio Inc. (NUVB)

Nuvation Bio Statistics

Total Valuation

Nuvation Bio has a market cap or net worth of $766.65 million. The enterprise value is $479.10 million.

Market Cap	766.65M
Enterprise Value	479.10M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Nuvation Bio has 334.78 million shares outstanding. The number of shares has increased by 3.12% in one year.

Current Share Class	333.78M
Shares Outstanding	334.78M
Shares Change (YoY)	+3.12%
Shares Change (QoQ)	+11.73%
Owned by Insiders (%)	24.95%
Owned by Institutions (%)	40.52%
Float	232.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.21
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	333.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.49, with a Debt / Equity ratio of 0.03.

Current Ratio	11.49
Quick Ratio	11.37
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4,073.89

Financial Efficiency

Return on equity (ROE) is -88.30% and return on invested capital (ROIC) is -57.20%.

Return on Equity (ROE)	-88.30%
Return on Assets (ROA)	-54.38%
Return on Capital (ROIC)	-57.20%
Revenue Per Employee	$28,137
Profits Per Employee	-$10.01M
Employee Count	51
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +69.63% in the last 52 weeks. The beta is 1.36, so Nuvation Bio's price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	+69.63%
50-Day Moving Average	2.60
200-Day Moving Average	2.71
Relative Strength Index (RSI)	45.46
Average Volume (20 Days)	1,586,763

Short Selling Information

The latest short interest is 9.97 million, so 2.98% of the outstanding shares have been sold short.

Short Interest	9.97M
Short Previous Month	20.23M
Short % of Shares Out	2.98%
Short % of Float	4.30%
Short Ratio (days to cover)	5.79

Income Statement

In the last 12 months, Nuvation Bio had revenue of $1.44 million and -$510.72 million in losses. Loss per share was -$2.27.

Revenue	1.44M
Gross Profit	88,000
Operating Income	-537.75M
Pretax Income	-510.72M
Net Income	-510.72M
EBITDA	-537.34M
EBIT	-537.75M
Loss Per Share	-$2.27

Balance Sheet

The company has $577.17 million in cash and $14.68 million in debt, giving a net cash position of $562.49 million or $1.68 per share.

Cash & Cash Equivalents	577.17M
Total Debt	14.68M
Net Cash	562.49M
Net Cash Per Share	$1.68
Equity (Book Value)	532.13M
Book Value Per Share	1.03
Working Capital	536.08M

Cash Flow

In the last 12 months, operating cash flow was -$84.21 million and capital expenditures -$62,000, giving a free cash flow of -$84.27 million.

Operating Cash Flow	-84.21M
Capital Expenditures	-62,000
Free Cash Flow	-84.27M
FCF Per Share	-$0.25

Margins

Gross Margin	6.13%
Operating Margin	-37,474.15%
Pretax Margin	-35,590.24%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-5,871.64%

Dividends & Yields

Nuvation Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.12%
Shareholder Yield	-3.12%
Earnings Yield	-66.62%
FCF Yield	-10.99%

Analyst Forecast

The average price target for Nuvation Bio is $6.17, which is 169.43% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.17
Price Target Difference	169.43%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	5.32%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nuvation Bio has an Altman Z-Score of 0.55 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.55
Piotroski F-Score	1